(Q37951523)

25 August 2017

title

Improving immunogenicity and effectiveness of influenza vaccine in older adults (English)

1 reference

25 August 2017

1 reference

David K Shay

6

0 references

Suryaprakash Sambhara

7

object named as

Suryaprakash Sambhara

1 reference

25 August 2017

Weiping Cao

1

1 reference

25 August 2017

Jin Hyang Kim

2

1 reference

25 August 2017

Tatiana Chirkova

3

1 reference

25 August 2017

Adrian J Reber

4

1 reference

25 August 2017

Renata Biber

5

1 reference

25 August 2017

publication date

1 November 2011

1 reference

Expert Review of Vaccines

25 August 2017

published in

1 reference

25 August 2017

volume

10

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1529-1537

1 reference

The role of epigenetics in aging and autoimmunity

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Phagocytosis of microbes: complexity in action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Age effects on macrophage function vary by tissue site, nature of stimulant, and exercise behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Innate immunity in aging: impact on macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Enhanced immune responses and resistance against infection in aged mice conferred by Flu-ISCOMs vaccine correlate with up-regulation of costimulatory molecule CD86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Intrinsic versus environmental influences on T-cell responses in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Dysregulation of human Toll-like receptor function in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Analysis of the human thymic perivascular space during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Increased activity of caspase 3 and caspase 8 in anti-Fas-induced apoptosis in lymphocytes from ageing humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

The influence of age on T cell generation and TCR diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

B-cell diversity decreases in old age and is correlated with poor health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Influenza: historical aspects of epidemics and pandemics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Seasonal influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Effectiveness of influenza vaccine in the community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Antibody response to influenza vaccination in the elderly: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Inactivated influenza vaccines: recent progress and implications for the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

21 January 2018

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

MF59 adjuvant: the best insurance against influenza strain diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Immunogenicity profile of a 3.75-μg hemagglutinin pandemic rH5N1 split virion AS03A-adjuvanted vaccine in elderly persons: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

Peripheral blood dendritic cells and monocytes are differently regulated in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.137

21 January 2018

Identifiers

DOI

10.1586/ERV.11.137

1 reference

25 August 2017

1 reference